李群 副主任医师，讲师
硕士招生类型：
硕士招生专业：
博士招生类型：
博士招生专业：
所在院系：附属东方医院
联系方式：yiru2013@126.com；liqun@fudan.edu.cn
课题组链接：
研究方向
主要任职
科研业绩


1. 肿瘤的早期诊断、发病机理和对策
2. 各种组学筛选到的标记物在肿瘤中的作用及其靶位治疗的研究

3. 纳米技术结合各种组学技术在肿瘤中的转化医学研究

Early diagnosis, pathogenesis and measures of oncology.
The research on the function and target therapy of various omics screening markers in tumors.
The translational research in tumors using nanotechnology combined with various omics technologies.







哈佛大学长木转化医学中国计划青年学术委员会委员
上海市医学会肿瘤专业委员会青年委员
美国临床肿瘤学会(ASCO)会员
美国癌症研究协会(AACR)会员
中国临床肿瘤学会（CSCO）会员
担任《转化医学电子杂志》国际编委

Committee Member, Young Academic Committee of China Program of Chang-Mu transform medicine in Harvard University
Youth Committee Member, Cancer Professional Committee of Medical Association in Shanghai
The member of American Society of Clinical Oncology
The member of American Association of Cancer Research
The member of Chinese Society of Clinical Oncology
The international editor of the transform medical electronic magazine





医学博士、博士后（复旦大学附属肿瘤医院），上海市同济大学附属东方医院肿瘤内科副主任医师，上海同济大学医学院、大连医科大学及南京医科大学硕士研究生导师。2016年公派至斯坦福大学医学院进行博士后研究，主要从事肿瘤基因组和免疫治疗的研究工作。承担国家自然科学基金、上海市自然科学基金、上海市浦东新区创新发展基金、上海市浦东新区卫生局等多项课题，近5年以第一或通讯作者身份发表SCI文章7篇，获得国家发明专利1项，并入选“优秀青年医学人才”及首届益大杯“青年医学之星”。

I am a medical Ph.D, Postdoctoral from FudanUniversity Affiliated Tumor Hospital. Now I am an associate chief physician ofoncology department in Shanghai East Hospital of Tongji University. I am also amaster tutor of Tongji University in Shanghai, Dalian Medical University andNanjing Medical University. I am completing postdoctoral at Stanford Universitystart from 2016 years, and mainly engaged in the research work of tumor genomeand immunotherapy. In the past 5 years, I have published 7 SCI papers andhosted 4 research projects. I have also participated in many national levelresearch projects and obtained 1 patent. I was selected as "outstandingyoung medical talent" and won the first batch of "Youth MedicalStar" award.